2021 Substance Abuse Management Virtual Master Class:
Effective Strategies for Safely Managing Changes to
Cannabis & Drug Testing Laws

May 11-12, 2021 | 12:00 PM to 4:00 PM EST daily | Virtual

Register Today

Overview

Recent state regulatory developments regarding medical and recreational marijuana have created a complex web of compliance concerns for employers as they try to navigate drug testing policymaking and substance abuse management in the workplace. As of Spring 2021, 17 states, the District of Columbia, and all U.S. territories have legalized the recreational use of marijuana, while 36 states, D.C., and the territories now permit the use and sale of medical cannabis products. At the federal level, President Joe Biden has pledged to legalize cannabis as part of his social justice initiatives, and this will be the game-changer that will create new obligations for employers under the Americans with Disabilities Act (ADA).

A sweeping opioid abuse epidemic further compounds substance abuse prevention challenges, requiring that employers maintain a delicate balance among business objectives, employee rights, and ADA requirements. Overdoses in the workplace can also have Occupational Safety and Health Administration (OSHA) implications, as can exposing workers to the perils of impaired coworkers or contractors. OSHA will also likely be changing its policy (again) on when employers can legally drug test injured workers post-accident.

It’s in an employer’s best interest to be proactive on this issue. According to the National Safety Council, the estimated yearly economic impact of substance use disorders exceeds $400 billion. Employers in all industries assume a significant share of these costs in the form of absenteeism, increased healthcare expenses, lost productivity, and a higher risk of workplace injuries resulting from safety lapses. On the other end, each employee who recovers from a substance abuse disorder saves a company more than $3,200 a year.

This 2-day, comprehensive virtual master class will provide practical information on and strategies to address these sensitive and increasingly prevalent workplace issues.

You’ll learn:

  • Best practices and legal limits on drug testing;
  • Post-accident drug testing best practices and strategies to protect safety while avoiding retaliation scrutiny from OSHA;
  • How to address emerging safety, practical, and legal considerations surrounding medical and recreational marijuana use;
  • Steps you can take to address the health and safety concerns associated with both prescription and illegal opioids while respecting worker privacy under the Health Insurance Portability and Accountability Act (HIPAA) and other relevant laws; and
  • Ways you can leverage employee assistance plans and other benefit programs to prevent and combat addiction and provide resources to aid in recovery.

Industry Leading Speakers

  • Adele Abrams

    Esq., CMSP

    President, Law Office of Adele L. Abrams PC

Agenda At A Glance

Tuesday, May 11, 2021
1 Hour
How, When, and Why You Should Drug Test: Legal Limits on Policy Development and Enforcement
1 Hour
Post-Accident Drug Testing and Safety Incentive Programs: How to Comply with OSHA’s ‘Reasonable’ Reporting and Antiretaliation Provisions
1 Hour
Medical and Recreational Marijuana at Work: Multistate Updates for Emerging Compliance Obligations
30 Minutes
Q&A with Presenter
Wednesday, May 12, 2021
1 Hour
The Opioid Epidemic: Steps You Can Take to Manage Effects, Combat Worker Addiction, and Limit Your Legal Liabilities
1 Hour
How Employee Benefit Programs, Including Workers’ Compensation, Health Insurance, and Employee Assistance Programs, Can Help Employees Recover from Addiction
1 Hour
Substance Abuse: The ADA, FMLA, and Related State Laws
30 Minutes
Q&A with Presenter